[EN] ESKETAMINE FORMULATIONS AND METHODS FOR PREPARATION AND STORAGE<br/>[FR] FORMULATIONS D'ESKÉTAMINE ET LEURS PROCÉDÉS DE PRÉPARATION ET DE STOCKAGE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2021116498A1
公开(公告)日:2021-06-17
The disclosure is directed to pharmaceutical compositions comprising esketamine or a pharmaceutically acceptable salt thereof and an oxidative degradant. In certain aspects, the oxidative degradant is 6-(2-chlorophenyl)-6-oxohexanoic acid or a pharmaceutically acceptable salt thereof. Methods for limiting the formation of oxidative degradants in a pharmaceutical composition comprising esketamine or a pharmaceutically acceptable salt thereof are also disclosed.